Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Simms

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Nature Reviews. Disease Primers|May 19, 2016
Systemic sclerosisYannick Allanore, Robert Simms, Oliver Distler, et al.
The Journal of Investigative Dermatology|April 24, 2017
Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic SclerosisKatsunari Makino, Tomoko Makino, Lukasz Stawski, et al.
The Journal of Investigative Dermatology|September 6, 2017
Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis FibrosisTetsuo Toyama, Agnieszka P Looney, Brendon M Baker, et al.
Plos One|June 23, 2009
Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expressionTimothy R D J Radstake, Lenny van Bon, Jasper Broen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2020
ReplyRobert Spiera, Lorinda Chung, Tracy Frech, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosisRomy B Christmann, Percival Sampaio-Barros, Giuseppina Stifano, et al.
Journal of Scleroderma and Related Disorders|January 10, 2022
A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic SclerosisKristi Kong, Diane Koontz, Christina Morse, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Quality indicator set for systemic sclerosisDinesh Khanna, Otylia Kowal-Bielecka, Puja P Khanna, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 31, 2022
Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical TrialDinesh Khanna, Paul Caldron, Richard W Martin, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Nature Reviews. Disease Primers|May 19, 2016
Systemic sclerosisYannick Allanore, Robert Simms, Oliver Distler, et al.
The Journal of Investigative Dermatology|April 24, 2017
Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic SclerosisKatsunari Makino, Tomoko Makino, Lukasz Stawski, et al.
The Journal of Investigative Dermatology|September 6, 2017
Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis FibrosisTetsuo Toyama, Agnieszka P Looney, Brendon M Baker, et al.
Plos One|June 23, 2009
Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expressionTimothy R D J Radstake, Lenny van Bon, Jasper Broen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2020
ReplyRobert Spiera, Lorinda Chung, Tracy Frech, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosisRomy B Christmann, Percival Sampaio-Barros, Giuseppina Stifano, et al.
Journal of Scleroderma and Related Disorders|January 10, 2022
A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic SclerosisKristi Kong, Diane Koontz, Christina Morse, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Quality indicator set for systemic sclerosisDinesh Khanna, Otylia Kowal-Bielecka, Puja P Khanna, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 31, 2022
Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical TrialDinesh Khanna, Paul Caldron, Richard W Martin, et al.
Pageof 3